Earnings Call · Q1 FY2022·2022-05-05

Q1 22EPS +11.26%·Rev n/aQ4 21EPS -39.13%·Rev n/aQ3 21EPS +3.97%·Rev n/aQ2 21EPS -4.26%·Rev n/a⚠ consensus missing

Atara Biotherapeutics, Inc. ATRA

Eric Hyllengren — Vice President

Pascal Touchon — Chief Executive Officer

Jakob Dupont — Chief Medical Officer

+1.5%1d on move date+2.1% vs SPY3d−16.6%5d−23.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ATRA calls or request research access.

More ATRA calls Browse calls Request research access